Empowering Primary Care Through Evidence

PEER is a primary care led evidence based medicine team focused on providing relevant evidence to family physicians and primary care providers.

PEIP 2023 Registration Now Open.

The PEIP conference highlights clinically relevant primary care topics that combine evidence, experience, and patient values that is free of industry bias. The conference is fully accessible via virtual webcast or in-person at our conference venue.


See some of the sights of another great PEIP Conference. We thought it was great but don’t take our word for it read the post conference evaluations from our attendees.  If you would like to attend other great PEER events sign up for the PEER Newsletter. Also, stay alerted to all PEER news and be the first to get the scoop on our 2023 PEIP Conference, October 20-21, 2023!

CFPCLearn’s primary care focused library includes a variety of content including evidence summaries, videos, podcasts and interactive learning courses to support clinicians in their practice.

Most Recent Tools for Practice

Tools for Practice #347 Chlorthali-D’OH!: What is the best thiazide diuretic for hypertension?

Which thiazide diuretic is best at reducing cardiovascular events in hypertension?

Chlorthalidone and hydrochlorothiazide reduce the risk of cardiovascular events similarly, but the risk of hypokalemia hospitalization increases from 1.1% with hydrochlorothiazide to 1.5% with chlorthalidone over 2.4 years.
Read More

Tools for Practice #346 – Stress Urinary Incontinence: Pelvic floor exercises or pessary?

How effective are pelvic floor exercises or pessaries for stress urinary incontinence?

Pelvic floor exercises increase the proportion of women with symptom improvement (74% versus 11%) and patient satisfaction (71% versus 13%) compared to control over 1-6 months. Pessaries may reduce incontinence episodes compared to no treatment based on one small, 2-week study. Exercise may be slightly better than pessary at three months (example: more patients without bothersome symptoms) with less vaginal discharge at 12 months. Read More

Tools for Practice #345 – Fancy Creams for Scaly Skin: Topical calcineurin inhibitors for atopic dermatitis

What are the risks and benefits of topical calcineurin inhibitors for atopic dermatitis?

For improvement of atopic dermatitis, tacrolimus 0.1% is at least equivalent to moderate-potency topical corticosteroids. Pimecrolimus 1% is better than placebo, but likely inferior to tacrolimus 0.1% and moderate potency corticosteroids. Burning skin sensation is common early (30-50% of users) but tapers off for most (<10% at 6 months). Read More

Tools for Practice #344 Statins in Older Adults

In patients ≥65 years old, do the benefits of statins outweigh harms?

For primary prevention patients aged 65-75 years, statins likely result in a 16-39% relative reduction in major adverse cardiac events (MACE). For primary prevention patients aged >75, the benefit of initiating statins is unclear. However, there is no evidence to support stopping statins when primary prevention patients age over 75 (just because of age). For secondary prevention patients over 65 years (and over 75), statins result in ~20% relative reduction in MACE. Adverse events are similar to placebo. Read More

Tools for Practice #343 Less is More Unless it’s Sleep or Toilet Paper: Non-traditional lipoproteins for cardiovascular risk

In patients without established cardiovascular disease (CVD), can lipoprotein(a) or apolipoprotein B meaningfully improve standard CVD risk estimation?

Adding lipoprotein(a) or apolipoprotein B does not meaningfully improve cardiovascular risk prediction above standard risk factors (age, sex, blood pressure, total cholesterol/HDL, diabetes, smoking). Assess risk with CVD risk calculators and offer proven therapies as appropriate. Read More

PEER Values

When creating primary care education and programs, the PEER team focuses on minimizing bias, patient orientated outcomes, shared decision making, collaboration and most importantly simplicity.

Who is PEER?

Patients, Experience, Evidence and Research (PEER) was formed between a group of primary care providers who shared a common belief that evidence should be made accessible to all primary care providers. 

Follow @peerevidence on Instagram

Our Partners

Sign Up for the PEER Newsletter

Don’t miss out on the latest from PEER. Get first access the latest PEER research and notified when PEER releases new guidelines and tools.